Is Cerebral Angiography Safe for CADASIL Patients?
At a Glance
For people with CADASIL, catheter cerebral angiography is usually avoided for routine imaging because vascular fragility and impaired blood-flow regulation may add theoretical risk. MRA or CTA are often preferred, while urgent or treatment-changing situations may justify angiography.
In this answer
3 sections
For patients with CADASIL, conventional catheter cerebral angiography (often called a digital subtraction angiogram or DSA) carries generalized procedural risks that may be compounded by the disease’s underlying vascular fragility. While direct outcome studies measuring CADASIL-specific complication rates are limited [1], non-invasive imaging methods—such as MRA or CTA—are generally preferred [2]. Catheter angiography should be avoided unless absolutely necessary, such as when it will directly change urgent or procedural management [2] [3].
Why Catheter Angiography is a Concern in CADASIL
CADASIL is caused by mutations in the NOTCH3 gene, which leads to a progressive loss of vascular smooth muscle cells located in the middle layer (tunica media) of small and medium-sized arteries [4] [5]. Over time, this healthy muscle tissue is replaced by stiff, fibrous material [6].
Although CADASIL primarily affects smaller brain arterioles rather than the large arteries where a catheter is navigated, the widespread structural damage causes biological vascular instability [4] [6]. Catheter angiography has known general risks for anyone—such as arterial dissection (a tear in the blood vessel wall), embolic stroke, access-site bleeding, and contrast reactions. However, neurologists and researchers raise biologically plausible concerns that CADASIL’s underlying fragility may lower the threshold for mechanical vascular injury during the procedure [1] [4].
Furthermore, CADASIL impairs cerebrovascular reactivity—the ability of blood vessels to properly react and adapt to changes in blood pressure and flow [7]. The temporary hemodynamic stress that occurs during a catheter angiogram could further compromise blood flow to the brain, adding theoretical risk to the procedure [8].
Safer Non-Invasive Alternatives
For the routine evaluation of CADASIL, MRI (Magnetic Resonance Imaging) is the principal imaging test [9] [3]. When your doctor needs to look closely at the blood vessels themselves, non-catheter-based imaging is generally the safest first step:
- MRA (Magnetic Resonance Angiography): Uses strong magnets to create detailed images of blood vessels. It avoids arterial catheterization and involves no ionizing radiation [9].
- CTA (Computed Tomography Angiography): Uses a standard CT scan with iodinated contrast dye injected through a regular arm IV to view the blood vessels. It does involve ionizing radiation and contrast, but avoids the risks of arterial catheterization [2] [3].
These non-invasive tools can answer many of the same diagnostic questions that an angiogram would, without threading a catheter into the arterial system [2] [3].
Comparing Vascular Imaging Options
| Feature | MRI / MRA | CTA | Catheter Angiography (DSA) |
|---|---|---|---|
| Invasiveness | Non-invasive (no arterial catheter) | Non-invasive (IV injection only) | Invasive (catheter threaded into arteries) |
| Radiation | None | Yes | Yes |
| Primary Use | Routine monitoring, baseline vessel imaging | Quick, detailed vessel evaluation | Dynamic flow analysis, precise surgical planning, interventions |
| Risks | Claustrophobia, rare contrast (gadolinium) reactions | Contrast allergy, kidney stress, radiation | Stroke, arterial tear (dissection), access-site bleeding, contrast allergy |
When Might a Catheter Angiogram Be Absolutely Necessary?
Despite the precautions, there are situations where a conventional catheter angiogram is absolutely necessary and should not be delayed [2]. This includes urgent, life-threatening conditions (like evaluating a bleeding aneurysm, severe vasospasm, or treating a large-vessel stroke) or when planning specific endovascular surgeries where non-invasive scans cannot provide the necessary dynamic flow or high-resolution detail.
In these situations, the immediate benefits of the procedure outweigh the theoretical risks. The decision should be individualized with your treating neurovascular team. It is important to have a shared decision-making conversation to ensure your neuro-interventionalist understands your CADASIL diagnosis, kidney function, current medications (like blood thinners), and any history of contrast allergies before proceeding.
Common questions in this guide
Is catheter cerebral angiography usually recommended for people with CADASIL?
Why might cerebral angiography be riskier with CADASIL?
Are MRA and CTA safer alternatives to a catheter angiogram for CADASIL?
When might someone with CADASIL still need a catheter angiogram?
What should I discuss with my care team before angiography?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What specific diagnostic or treatment decision will change based on the results of this catheter angiogram?
- 2.Would it be safe to wait and try a non-invasive test (like an MRA or CTA) first to see if it provides the necessary information?
- 3.How familiar is the neuro-interventionalist performing the procedure with CADASIL and the associated vascular fragility?
- 4.Given my CADASIL diagnosis, what specific precautions will the team take to minimize the risk of vessel injury or stroke during the procedure?
- 5.Which of my current medications (especially blood thinners or blood pressure medications) should I take or hold prior to this procedure?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (9)
- 1
Predictors of Clinical Worsening in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy: Prospective Cohort Study.
Chabriat H, Hervé D, Duering M, et al.
Stroke 2016; (47(1)):4-11 doi:10.1161/STROKEAHA.115.010696.
PMID: 26578659 - 2
Management of Inherited CNS Small Vessel Diseases: The CADASIL Example: A Scientific Statement From the American Heart Association.
Meschia JF, Worrall BB, Elahi FM, et al.
Stroke 2023; (54(10)):e452-e464 doi:10.1161/STR.0000000000000444.
PMID: 37602377 - 3
Clinical and research applications of magnetic resonance imaging in the study of CADASIL.
Schoemaker D, Quiroz YT, Torrico-Teave H, Arboleda-Velasquez JF
Neuroscience letters 2019; (698()):173-179 doi:10.1016/j.neulet.2019.01.014.
PMID: 30634011 - 4
CADASIL: A NOTCH3-associated cerebral small vessel disease.
Yuan L, Chen X, Jankovic J, Deng H
Journal of advanced research 2024; (66()):223-235 doi:10.1016/j.jare.2024.01.001.
PMID: 38176524 - 5
Insulin-Independent and Dependent Glucose Transporters in Brain Mural Cells in CADASIL.
Panahi M, Rodriguez PR, Fereshtehnejad SM, et al.
Frontiers in genetics 2020; (11()):1022 doi:10.3389/fgene.2020.01022.
PMID: 33101365 - 6
Therapeutic antibody targeting of Notch3 signaling prevents mural cell loss in CADASIL.
Machuca-Parra AI, Bigger-Allen AA, Sanchez AV, et al.
The Journal of experimental medicine 2017; (214(8)):2271-2282 doi:10.1084/jem.20161715.
PMID: 28698285 - 7
Mechanisms regulating cerebral hypoperfusion in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
Yan X, Shang J, Wang R, et al.
Journal of biomedical research 2022; (36(5)):353-357 doi:10.7555/JBR.36.20220208.
PMID: 36165325 - 8
Long-Term Treatment with the Calcitonin Gene-Related Peptide Receptor Antagonist Erenumab in CADASIL: Two Case Reports.
Albanese M, Pescini F, Di Bonaventura C, et al.
Journal of clinical medicine 2024; (13(7)) doi:10.3390/jcm13071870.
PMID: 38610637 - 9
CADASIL: Imaging Characteristics and Clinical Correlation.
Zhu S, Nahas SJ
Current pain and headache reports 2016; (20(10)):57 doi:10.1007/s11916-016-0584-6.
PMID: 27591799
This page explains imaging considerations for people with CADASIL for educational purposes only and does not replace advice from your neurologist or neuro-interventional team about whether angiography is appropriate for you.
Get notified when new evidence is published on Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.